First report of ipilimumab-induced Grover disease

British Journal of Dermatology

Volumn 171, Issue 5, 2014, Pages 1236-1237

  Munoz, J ^a   Guillot, B ^a   Girard, C ^a   Dereure, O ^a   Du Thanh, Aurélie ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACARBAZINE; IMMUNOGLOBULIN G1 ANTIBODY; IPILIMUMAB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ACANTHOLYSIS; ACANTHOLYTIC DYSKERATOSIS; ADULT; ALOPECIA; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DYSKERATOSIS; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; IPILIMUMAB INDUCED GROVER DISEASE; LETTER; MALE; MELANOMA; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PAPULAR RASH; PRURITUS; SKIN BIOPSY; TRANSIENT ACANTHOLYTIC DERMATOSIS; TREATMENT DURATION; TRUNK; VITILIGO; CHEMICALLY INDUCED; DRUG ERUPTIONS; ICHTHYOSIS; SKIN NEOPLASMS;

ACANTHOLYSIS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; HUMANS; ICHTHYOSIS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84910141354     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13058     Document Type: Letter

References (10)

1. Davis MD, Dinneen AM, Landa N, Gibson LE,. Grover's disease: clinicopathologic review of 72 cases. Mayo Clin Proc 1999; 74: 229-34.
2. Yaffee HS,. Possible dysglobulinemia and Grover's disease. Arch Dermatol 1981; 117: 3.
3. Parsons JM,. Transient acantholytic dermatosis (Grover's disease): a global perspective. J Am Acad Dermatol 1996; 35: 653-66.
4. Antunes I, Azevedo F, Mesquita-Guimaraes J, et al,. Grover's disease secondary to ribavirin. Br J Dermatol 2000; 142: 1257-8.
5. Zvulunov A, Grunwald MH, Avinoach I, Halevy S,. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine. Int J Dermatol 1997; 36: 476-7.
6. Crockett JS, Burkemper NM,. Grover disease (transient acantholytic dermatosis) induced by anastrozole. Cutis 2011; 88: 175-7.
7. Villalon G, Martin JM, Monteagudo C, et al,. Clinicopathological spectrum of chemotherapy induced Grover's disease. J Eur Acad Dermatol Venereol 2007; 21: 1145-7.
8. Anforth R, Fernandez-Penas P, Long GV,. Cutaneous toxicities of RAF inhibitors. Lancet Oncol 2013; 14: e11-18.
9. Minkis K, Garden BC, Wu S, et al,. The risk of rash associated with ipilimumab in patients with cancer: a systematic review of the literature and meta-analysis. J Am Acad Dermatol 2013; 69: e121-8.
10. Fischer A, Rosen AC, Ensslin CJ, et al,. Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4. Dermatol Ther 2013; 26: 135-48.